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Introduction
Inflammation is a protective mechanism of the body 
which leads to the loss of function of the affected area. 
Neuroinﬂammation is implicated in impairments in neu-
ronal function due to aging, trauma, and/or disease and 
is involved in the pathology of various acute and chronic 
brain diseases, including Alzheimer disease (1). It is well 
known that neuroinflammation impairs memory process-
ing during consolidation and retrieval stages and induce 
severe cognitive disturbances (2,3). The current treatment 
of inflammation includes compounds which inhibit pros-
taglandin synthesis, named nonsteroidal anti-inflamma-
tory drugs (NSAIDs). These anti-inflammatory drugs are 
associated with a variety of severe side effects (4). There 
is currently a high demand for natural therapies to treat 
inflammation and reduce the side effects of drugs used 
in the clinic (5). The Boswellia species (Burseraceae) are 
trees native to Ethiopia, Somalia, India, and the Arabic 
peninsula. They produce a gum resin that is known as 
frankincense (olibanum). The putative anti-inflammatory 
activity of frankincense has been approved using differ-
ent models of inflammation (6-8). The resin of Boswellia 
carteri has been used for the treatment of inﬂammatory 
diseases in the traditional medicine in several countries 
(7). In addition, no significant side effects or toxicity have 
been reported from frankincense and one of its major 
constituents, boswellic acids (9). 
The beneficial effects of frankincense have been shown 
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Introduction: Frankincense has been shown to possess anti-inflammatory activity. In this study 
the effect of pretreatment with the hydro-alcoholic extract of frankincense on memory retrieval 
was assessed in lipopolysaccharide (LPS) treated rats. 
Methods: Forty-two adult male Wistar rats were distributed into 7 groups of 6 each. One group 
received LPS (1 mg/kg; i.p) pre-test. The control group received saline (1 ml/kg; i.p). 2 groups of 
animals received frankincense (50 mg/kg; P.O) or DMSO 5% (1 ml/kg; P.O) and 30 minutes later 
LPS (1 mg/kg; i.p). Two other groups of animals received frankincense (50 mg/kg; P.O) or DMSO 
5% (1 ml/kg; P.O) and 30 minutes later saline (1 ml/kg; i.p). Another group of rats received LPS 
(1 mg/kg; i.p) and 30 minutes later Ibuprofen (100 mg/kg; P.O). In all the experimental groups, 
memory retrieval was assessed 4 hours following the last injection, using a passive avoidance 
task (PAT). Hippocampal TNF-α levels were measured by ELISA as an index of LPS-induced 
neuroinflammation.
Results: LPS impaired memory retrieval by decreasing step-through latency (STL), significantly. 
LPS also increased levels of TNF-α in the hippocampus as compared to the control group. 
Administration of frankincense (50 mg/kg; P.O) before LPS (1 mg/kg; i.p) improved memory 
retrieval as compared to the control group. Frankincense reduced hippocampal TNF-α level in the 
LPS treated rats, significantly, compared to the control group.
Conclusion: The results indicate that the hydro-alcoholic extract of frankincense has the potential 
to improve memory retrieval in LPS treated rats, possibly via an anti-neuroinflammatory activity.
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Frankincense improves memory retrieval
Journal of HerbMed Pharmacology, Volume 5, Number 1, January 2016http://www.herbmedpharmacol.com 13
on memory, both in normal and impaired memory condi-
tions. For example, frankincense was shown to enhance 
the retention phase of spatial memory in the Morris wa-
ter maze (10). It could prevent hypothyroidism induced 
spatial memory impairment in rats (11) and induced sig-
nificant improvement in visuospatial memory in multiple 
sclerosis patients (12). 
Lipopolysaccharide (LPS) is the active fragment of gram-
negative bacteria. Systemic administration of LPS has 
been extensively used to induce neuroinflammation. 
Peripheral inﬂammation induced by LPS produces a 
neuroinﬂammatory response involving blood-brain bar-
rier, glia and neurons (1). 
Despite the fact that frankincense has potential anti-
inflammatory activity and beneficial effects on memory 
formation, the impact of frankincense on neuroinflamma-
tion induced memory impairment have not been studied. 
Therefore, the aim of the present study was to examine 
whether acute administration of the hydro-alcoholic ex-
tract of frankincense from Boswellia carteri could improve 
memory loss induced by LPS.
Materials and methods
LPS was purchased from Sigma (USA). LPS was dissolved 
in sterile saline. Frankincense from Boswellia carteri was 
donated by Raha Pharmaceutical Company (Isfahan, 
Iran). Protease inhibitor cocktail was purchased from 
Roche (Germany). Rat TNF-α ELISA kit was purchased 
from Boster (USA).
Preparation of the hydro-alcoholic extract of frankincense
The species origin of frankincense was identified by an 
expert botanist. An appropriate amount of the resin of 
Boswellia carteri was pulverized and soaked in 96% etha-
nol. After 24 hours the ethanol was evaporated in rotary 
equipment. The remaining crude was dissolved in DMSO 
5% (V/V in saline) and filtered before injection, then was 
warm-heated on a 50°C water bath for 60 minutes and 
cooled at room temperature before injection. The volume 
of the extract for gavage injection was 1 ml/kg. The dose 
of frankincense (50 mg/kg; P.O) was selected according to 
previous reports indicating the effectiveness of it on cog-
nitive functions (13). 
Animals
Totally 42 male Wistar rats weighing 230-280 g were ob-
tained from the breeding colony of Department of Biol-
ogy, University of Isfahan and randomly distributed into 
7 groups of 6 each. Rats were housed four per cage in a 
temperature (24°C) controlled room that was maintained 
on a 12:12 light cycle (light on at 07:00 am). Rats had un-
restricted access to food and water in their home cage. All 
experiments were executed in accordance with the guide-
lines for the care and use of laboratory animals (National 
Institute of Health publication No. 80-23, revised 1996) 
and were approved by the graduate studies committee of 
the Department of Biology, University of Isfahan.
Passive avoidance task
The step-through passive avoidance paradigm was per-
formed as previously described (14). Briefly, each rat was 
placed in the white chamber of the passive avoidance task 
(PAT) apparatus facing the sliding door. After 5 seconds 
the door was raised. When the animal stepped into the 
dark chamber with all four paws, the door was closed and 
the rat remained there for 20 seconds. Then the animal 
was removed to be placed in a temporary cage. 30 minutes 
later, the rat was again placed in the white chamber for 5 
seconds, then the door was raised to let the animal enter 
the dark chamber and following entrance, the door was 
closed, but this time a controlled electrical shock of 0.3 
mA lasting for 1 second was delivered. After 20 seconds, 
the rat was placed into the temporary cage. Two minutes 
later, the same testing procedure was repeated. When the 
rat remained in the white compartment for a 2-minute 
times period, the training was terminated. On the second 
day, a retrieval test was performed to evaluate long-term 
memory. Each animal was placed in the white start cham-
ber for 20 seconds, then the door was raised and the step-
through latency (STL), was recorded, up to 600 seconds.
ELISA assay
Immediately following completion of the behavioral tests, 
rats were euthanized and their hippocampi were removed 
and frozen in liquid nitrogen, then were stored in -80°C 
freezer. Each sample of hippocampus was homogenized 
in 320 μl of cold buffer (Tris-HCL 50mM, Nacl 150mM, 
Sodiumdeoxycholate 0.25%, SDS 0.1%, EDTA 1mM, pro-
tease inhibitor cocktail 5%; pH = 7.2) and centrifuged at 
12000 rpm for 30 minutes at 4°C. Total protein concen-
tration of supernatant was determined by Bradford assay 
(15). TNF-α levels were measured by ELISA kit accord-
ing to the manufacturer’s instruction (Boster Biological 
Technology Co., Ltd.). Concentration of the cytokine was 
quantified as pg of antigen per 10 μg of total protein.
Experiment 1
Six animals were used in each experimental group. In this 
experiment, 2 groups of animals received LPS (1 mg/kg; 
i.p) or saline (1 ml/kg; i.p) on the test day and 4 hours later 
memory retrieval was assessed. 
Experiment 2
In this experiment, 2 groups of animals received the 
hydro-alcoholic extract of frankincense (50 mg/kg; P.O) 
or DMSO 5% (1 ml/kg; P.O) and 30 minutes later saline 
(1 ml/kg; i.p) pre-test (24 hours after training). Two other 
groups of animals received the hydro-alcoholic extract of 
frankincense (50 mg/kg; P.O) or DMSO 5% (1 ml/kg; P.O) 
and 30 minutes later LPS (1 mg/kg; i.p) pre-test. Another 
group of animals received ibuprofen (100 mg/kg; P.O) and 
30 minutes later LPS (1 mg/kg; i.p). Four hours after the 
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last injections, memory retrieval was assessed.
Statistical analysis
The data are presented as mean ± SEM. One-way analysis 
of variance (ANOVA) with Tukey-Kramer multiple com-
parisons post hoc test or unpaired t test were performed 
for data analysis. In all the experiments, P < 0.05 was con-
sidered statistically significant.
Results
The effect of systemic administration of LPS on memory 
retrieval
In the PAT, the decrease in STL indicates loss of memory. 
The intra-peritoneal administration of LPS (1 mg/kg) 4 
hours pre-test, impaired memory retrieval. Un-paired 
t test indicated that LPS decreased STL in a significant 
manner (P < 0.05). The ELISA assay results showed that 
LPS increased TNF-α levels in the hippocampus of rats, 
significantly compared to the control group (P < 0.05).
The effect of the hydro-alcoholic extract of frankincense 
and Ibuprofen on memory retrieval in rats treated with 
LPS 
One-way ANOVA indicated significant main effect of 
STL in animals treated with the hydro-alcoholic extract of 
frankincense (50 mg/kg) before LPS (1 mg/kg) [F (2, 17) = 
4.135; P = 0.03]. Post-hoc comparison showed that frank-
incense significantly increased STL as compared with the 
group received DMSO 5% and LPS (Figure 1; P < 0.05). 
Injection of Ibuprofen (100 mg/kg) after LPS (1 mg/kg) 
increased STL, significantly as compared with the group 
received DMSO 5% and LPS (Figure 1; P < 0.05).
One-way ANOVA indicated significant decrease of 
TNF-α levels in the hippocampus of rats [F (2, 17) = 12.32; 
P = 0.0007]. Post-hoc comparisons showed that injection 
of frankincense (50 mg/kg) and ibuprofen (100 mg/kg) 
before or after LPS, respectively, decreased TNF-α levels 
in the hippocampus of rats significantly, compared with 
the group received DMSO 5% and LPS (Figure 2; P < 0.01 
and P < 0.001).
Discussion
We found that systemic administration of LPS 4 hours 
pre-test increased the levels of TNF-α in the hippocam-
pus, which indicated that it had induced neuroinflam-
mation. It also impaired memory retrieval in the passive 
avoidance paradigm. These findings are in accordance 
with previous reports, showing the effect of LPS induced 
neuroinflammation on memory impairment (4).
The main outcome of the present study was that the 
hydro-alcoholic extract of frankincense could improve 
memory retrieval in rats treated with acute intra-perito-
neal injection of LPS. More than 200 different compounds 
have been identified in the oleo-gum resin of different Bo-
swellia species (16). These include monoterpenes, diter-
penes, triterpenes, pentacyclic triterpenic acids (boswellic 
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Figure 1. The effects of pre-test administration of the hydro 
alcoholic extract of frankincense (50 mg/kg; P.O) and ibuprofen 
(100 mg/kg; P.O) before and after administering LPS (1 mg/kg; 
i.p), respectively, on STL. Data are expressed as means ± S.E.M. 
*P < 0.05.
Figure 2. The effects of pre-test administration of the hydro 
alcoholic extract of frankincense (50 mg/kg; P.O) and ibuprofen 
(100 mg/kg; P.O) before and after administering LPS (1 mg/
kg; i.p), respectively, on hippocampal TNF-α levels. Data are 
expressed as means ± SEM. **P < 0.01; ***P < 0.001.
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acids) and tetracyclic triterpenic acids. It was reported 
that pure compound of frankincense exhibit anti-inflam-
matory property in human peripheral blood mononuclear 
cells and mouse macrophages through inhibition of tumor 
necrosis factor-alpha, interleukin-1 beta, NO and mito-
gen activated protein kinases (9). Boswellic acids are the 
main active components of the resin of Boswellia carteri 
which deal with the ethnomedicinal use for the treatment 
of inflammatory diseases (7). Boswellic acids were shown 
to specifically inhibit the synthesis of pro-inflammatory 
enzyme, 5-lipooxygenase (5-LO). 5-LO generates inflam-
matory leukotrienes. Leukotrienes cause inflammation 
by promoting free radical damage, cell adhesion and mi-
gration of inflammation-producing cells to the inflamed 
zone. Boswellic acids are specific inhibitors of leukotri-
enes, which interact directly with 5-LO or block its trans-
location. Boswellic acids were also shown to downregulate 
the pro-inflammatory cytokines including TNF-α, IL-1β, 
IL-2, IL-6 and INF-γ by interacting with the production/
release of these cytokines (8). Another active compo-
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nent of frankincense, incensole acetate, was also shown 
to inhibit activation of nuclear factor-kappa B (NF-кB), 
a transcription factor which is crucial for inflammatory 
responses (17).
In accordance to the anti-inflammatory activities of frank-
incense, the results of the present study indicated that the 
hydro-alcoholic extract of frankincense decreased the 
levels of TNF-α in the hippocampus of rats treated with 
LPS, significantly. TNF-α is involved in inflammatory re-
actions. Inhibition of TNF-α and its signaling is a highly 
successful strategy for the treatment of inflammatory dis-
eases (16). Our finding showed that the hydro-alcoholic 
extract of frankincense could induce an anti-neuroinflam-
matory activity, which was comparable with the putative 
NSAID, Ibuprofen. In support of this finding, different 
doses of frankincense have also inhibited generation of 
TNF-α by human monocytes stimulated with LPS by a di-
rect inhibitory action on Iк Bα kinases (IKK), conveyed 
inhibition of NF-кB and subsequent down-regulation of 
TNF-α (18). Also, chronic administration of a methano-
lic extract of frankincense possessed anti-inflammatory 
effect against neuroinflammation characterizing AlCl3 
Alzheimer disease in rats (19). Therefore, owing to an 
evident effect of frankincense on decreasing an important 
pro-inflammatory cytokine (TNF-α) in the hippocampus 
of rats, it appears that frankincense was able to improve 
cognitive functions probably due to anti-neuroinflamma-
tory property.
In the present study, we administered frankincense 30 
minutes before LPS injection. This was because it was re-
ported that boswellic acids from frankincense directly tar-
get LPS rather than unspecifically interacting with other 
molecules in downstream LPS signaling (20). According-
ly, it is probable that boswellic acids of frankincense might 
even have prevented initiation of neuroinflammation. 
A number of previous studies have indicated that frank-
incense has beneficial effects on memory, both on normal 
brain (10) and on impaired memory conditions (11,13). It 
was argued that the effect of frankincense on memory is 
mainly due to structural alterations in the brain neuronal 
circuits (21). For example, chronic maternal administra-
tion of Boswellia gum resin in gestational period induced 
significant volumetric alteration in the layers of the CA3 
hippocampal field in young male rats (22). Also, different 
doses of frankincense was shown to increase the number 
of neurons and dendritic spines in hippocampal region 
CA1 in rats (23). For this reason, in most of the studies as-
sessing the effect of frankincense on memory, the extracts 
were administered chronically. In the present study, we 
administered the hydro-alcoholic extract of frankincense, 
acutely and 4.30 hours pre-test. Our results indicated 
that frankincense, showed a tendency towards improv-
ing memory parameters (data not shown), but failed to 
be statistically significant. Therefore, it is unlikely that the 
direct effect of frankincense on improvement of memory 
in LPS treated rats were involved in the observed results. 
We hypothesize that the major effect of frankincense on 
improvement of memory retrieval observed in the present 
study might be due to its anti-neuroinflammatory proper-
ty rather than its direct beneficial effects on memory. Fur-
ther studies are required to clarify whether the acutely ad-
ministered frankincense could also induce functional and 
structural changes related to the improvement of memory, 
in brain areas related to memory processing. 
Conclusions
In conclusion, our results indicated that the hydro-alco-
holic extract of frankincense could prevent memory loss 
caused by systemic administration of LPS. The anti-neu-
roinflammatory activity of frankincense which was com-
parable with the putative NSAID, Ibuprofen, is suggested 
to be involved in the observed results. 
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